LabCompass

Hadi M. Yassine

Medicine · Indiana University

OpenAlex ORCID
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testingRespiratory viral infections researchInfluenza Virus Research Studies

Publications

386

Citations

17,436

Est. group size

—

Recurring co-author estimate

Active years

24

Publishing since 2003

Research summary
AI-generated

Hadi M. Yassine studies infectious diseases, with a strong focus on viruses such as SARS-CoV-2 (the virus that causes COVID-19), influenza, and other respiratory and zoonotic (animal-to-human) pathogens. The research spans vaccine effectiveness, immune responses to infection, laboratory detection methods, and computational approaches to finding drug targets. Recent work also includes population-level studies of disease spread and severity as well as molecular and biosensor tools for detecting viral proteins.

SARS-CoV-2 and COVID-19 researchVaccine effectiveness and immune protectionRespiratory and zoonotic virus surveillanceViral detection and diagnostic methodsComputational drug and target discovery

Publication output grew sharply around 2020-2021 and has since settled to a slightly lower but steady pace of roughly 40 papers per year.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 38.6/year recently
2017: 2 publications172018: 14 publications182019: 24 publications192020: 49 publications202021: 71 publications71212022: 65 publications222023: 46 publications232024: 38 publications242025: 41 publications252026: 3 publications26
Recent publications
Publishes in
  • medRxiv×59
  • University of the Future: Re-Imagining Research and Higher Education×12
  • PLoS ONE×10
  • Scientific Reports×10
  • Journal of Infection and Public Health×9

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile